8th Symposium on Biologic Scaffolds for Regenerative Medicine

描述（由申请人提供）：1996年在佛罗里达州奥兰多举行的国际组织工程学会（TESI）第一次会议上，认识到需要召开一个相对较小的会议，重点讨论生物支架在再生医学中的作用。与TESE会议共同定位，我们举行了这个研讨会系列的第一次会议，每2-3年组织一次，目的是促进生物支架在再生医学和所有普通外科和重建应用中的使用。该提案要求部分支持第八届再生医学生物支架研讨会，因为它第三次返回加州纳帕的西尔维拉多度假村。确认日期为2014年4月24日至26日。大约有100- 150名与会者，本次研讨会的目标将通过一系列客观的演讲来实现，这些演讲描述了这些材料的优点和缺点，影响临床前和人类临床性能的因素，以及可能从其使用中受益最多的临床应用。该计划将分为5个会议，主题从分子水平的支架重塑的最基础科学到临床前和临床水平。具体的主题将集中在决定对支架材料的热反应的关键因素上，例如源组织变量、去细胞化和灭菌方法以及质量保证标准。重要的是，本次研讨会的目的不仅是讨论生物支架的有益方面，而且同样重要的是确定问题领域，制定解决这些问题的策略，并希望在出席会议的基础科学家，临床医生和行业代表之间开展合作。主题演讲者和受邀演讲者被认为是其研究领域最重要的专家。跨专业的研究方法有助我们更深入了解与健康相关的问题。目标受众包括生物支架领域新的和有经验的研究人员、学生（研究生和博士后）、医生和对这些器械类型的治疗机会感兴趣的商业实体。初级研究人员和学生将获得一个场地，介绍和讨论他们的研究在海报会议和邀请讲台演示。从历史上看，这个研讨会主要吸引了男性调查人员和行业代表。重要的是要 请注意，在12位已确认的专题发言人中，有6位是女性科学家（占50%）。第三部分完全是乳房和骨盆底的重建手术。该提案的目的是支持学生和女性受训者积极参与。因此，将向这两个代表性不足的群体分配资金，以帮助支付会议登记、差旅、每日津贴和/或住宿费用。所有旅行奖获得者将被要求提交一份海报，并将根据成绩选出少数人在讲台上介绍他们的工作。

DESCRIPTION (provided by applicant): The need for a relatively small meeting focused upon the role of biologic scaffolds in regenerative medicine was recognized at the first meeting of the Tissue Engineering Society International (TESI) in Orlando, FL, 1996. Co-localized with the TESE meeting, we held the first meeting in this symposia series, which is organized every 2-3 years, with the goal of advancing the use of biologic scaffolds for regenerative medicine and for all general surgery and reconstructive applications. This proposal requests partial support for the 8th Symposium on Biologic Scaffolds for Regenerative Medicine as it returns to the Silverado Resort in Napa, California for the third time. Confirmed dates are April 24-26, 2014. With approximately 100- 150 attendees, this symposium's aims will be realized via a series of objective presentations describing the pros and cons of such materials, factors that affect preclinical and human clinical performance, and the clinical applications that may benefit most from their use. The program will be structured into 5 sessions with themes ranging from the most basic science of scaffold remodeling at the molecular level through the preclinical and clinical level. Specific subject matter will be focused upon critical factors that determine the hot response to the scaffold materials such as source tissue variables, methods of decellularization and sterilization, and quality assurance criteria. It is significant that the intent of this symposum is to not only discuss the beneficial aspects of biologic scaffolds, but just as importantly to identify the problem areas, develop strategies for solving these problems, and hopefully initiate collaborations among basic scientists, clinicians, and industry representatives in attendance at the meeting. Keynote and invited speakers are considered the foremost experts in their research niche. The cross disciplinary approach will facilitate the understanding of relevant health relatedness issues at a more in-depth level. The target audience includes both new and experienced investigators in the biologic scaffolds field, students (graduate and postdoctoral), physicians, and commercial entities interested in therapeutic opportunities with these device types. Junior investigators and students will be given a venue to present and discuss their research in poster sessions and invited podium presentations. Historically, this symposium has attracted primarily established male investigators and industry representatives. It is important to note that of the 12 confirmed and featured speakers, for this next symposium 6 are female scientists (50%). Session III is devoted entirely to reconstructive surgery of the breast and pelvi floor. The purpose of this proposal is to support robust participation by the student and female trainee populations. As such, funds will be allocated toward these 2 underrepresented populations to help cover conference registration, travel, per diem, and/or lodging expenses. All travel awardees will be required to submit a poster for presentation and a handful will be chosen by merit to present their work on the podium.